Revolution Medicines' pancreatic cancer drug daraxonrasib succeeds in trial
Medicines of the revolution'The pancreatic cancer drug was successful in a highly anticipated Phase 3 trial, nearly doubling the typical…
business news
Novo Nordisk partners with OpenAI as hopes rise for AI drug discovery
Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.…
How Kodak is trying to turn around after teetering on the brink of bankruptcy
On Jim Continenza's first day on the job as Kodak CEO in 2019, he received a call from a star…
Tech entrepreneur mom creating AI agent for families with rare diseases
Farid Vij, CEO and Co-Founder of Citizen Health, and Nasha Fitter, Chief Business Officer and Co-Founder of Citizen Health. Citizen…
The European pharmaceutical industry is in danger from Trump's policies and China's biotech boom
Boxes of medicines are seen on the shelves of Keencare pharmacy, a member of the Green Light Group, on September…
Chrysler CEO touts minivan 'resurgence' but stays mum on plans
Matt McAlear, CEO of Chrysler and Dodge, wants the world to know that the minivan is not dead. Far from…
Ben Sasse highlights daraxonrasib for pancreatic cancer
Medicines of the revolution could be on the cusp of a breakthrough. The company hopes to soon publish results from…
Delta and Southwest raise checked bag fees by $10 amid rising jet fuel prices
A Delta Air Lines Airbus A350 aircraft lands at Los Angeles International Airport after arriving from Atlanta on March 7,…
Trump administration finalizes Medicare Advantage payment rate
Centers for Medicare and Medicaid Services Administrator Mehmet Oz speaks during an event sponsored by the Action for Progress Coalition,…
JPMorgan CEO Jamie Dimon's annual letter cites risks in geopolitics, artificial intelligence and private markets
JPMorgan Chase CEO Jamie Dimon calls for a broad commitment to American ideals as his bank navigates geopolitical uncertainty, a…